← Leaderboards
Michael Baumann
National Institute On Drug Abuse
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Drug Abuse
Same institution · by research overlap
Others in their field
Top investigators on “Serotonin”
- John P Capitanio · University Of California Davis$30,217,814
- Richard M Weinshilboum · Mayo Clinic Coll Of Medicine, Rochester$28,568,116
- Joseph J Mann · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc$26,490,622
- Gordon Stewart Mitchell · University Of Florida$21,198,903
- Bryan L Roth · Univ Of North Carolina Chapel Hill$18,357,105
- Constantine G Lyketsos · Johns Hopkins University$16,779,458
Research focus
SerotoninDopaminePharmaceutical PreparationsAnalogRattusDrug Of AbuseAddictionBindingBrainOpioidNeuronsExtracellularPublic HealthPublishingIn VivoIn VitroMonoaminePharmacologyInterestDopamine TransporterSynthetic OpioidSelf AdministrationAgonistAdverse Effects
Grant awards (20)
Pharmacology and toxicology of new psychoactive substances$1,357,963
ZIA · FY2025 · DA · contact PI
Preclinical medication development for stimulant use disorder$905,309
ZIA · FY2025 · DA · contact PI
Pharmacology and toxicology of new psychoactive substances$1,746,074
ZIA · FY2024 · DA · contact PI
Preclinical medication development for stimulant use disorder$748,318
ZIA · FY2024 · DA · contact PI
Pharmacology and toxicology of new psychoactive substances$1,642,819
ZIA · FY2023 · DA · contact PI
Preclinical medication development for stimulant use disorder$704,065
ZIA · FY2023 · DA · contact PI
Pharmacology and toxicology of new psychoactive substances$1,461,591
ZIA · FY2022 · DA · contact PI
Preclinical medication development for stimulant use disorder$626,396
ZIA · FY2022 · DA · contact PI
Pharmacology and toxicology of new psychoactive substances$1,202,384
ZIA · FY2021 · DA · contact PI
Preclinical medication development for stimulant use disorder$515,308
ZIA · FY2021 · DA · contact PI
Pharmacology and toxicology of newly-emerging designer drugs of abuse$1,321,257
ZIA · FY2020 · DA · contact PI
Medication development of agonist-type treatment agents for stimulant addiction$440,419
ZIA · FY2020 · DA · contact PI
Pharmacology and toxicology of newly-emerging designer drugs of abuse$1,122,362
ZIA · FY2019 · DA · contact PI
Medication development of agonist-type treatment agents for stimulant addiction$374,121
ZIA · FY2019 · DA · contact PI
Pharmacology and toxicology of newly-emerging designer drugs of abuse$1,110,742
ZIA · FY2018 · DA · contact PI
Medication development of agonist-type treatment agents for stimulant addiction$370,247
ZIA · FY2018 · DA · contact PI
Pharmacology and toxicology of newly-emerging designer drugs of abuse$1,115,953
ZIA · FY2017 · DA · contact PI
Medication development of agonist-type treatment agents for stimulant addiction$371,984
ZIA · FY2017 · DA · contact PI
Pharmacology and toxicology of newly-emerging designer drugs of abuse$1,057,325
ZIA · FY2016 · DA · contact PI
Medication development of agonist-type treatment agents for stimulant addiction$352,442
ZIA · FY2016 · DA · contact PI